Cited by 78COVID-19 Clinical Research StudiesCOVID-19 and healthcare impactsSARS-CoV-2 and COVID-19 Research

Diabetes mellitus association with coronavirus disease 2019 (COVID‐19) severity and mortality: A pooled analysis

Open access
Aggarwal, Gaurav, Lippi, Giuseppe, Lavie, Carl J., Henry, Brandon Michael, Sanchis‐Gomar, Fabian·2020·Journal of Diabetes

Abstract

Highlights There are ~ 2-fold increased odds of severe coronavirus disease 2019 (COVID-19) and a ~ 2-fold increased risk of odds of mortality in patients with history of diabetes mellitus compared to those without diabetes mellitus. Patients with a history of diabetes mellitus should be closely monitored if they get infected with COVID-19. Results of meta-analysis showing association of diabetes mellitus with severity (Panel A) of disease and mortality (Panel B) in coronavirus disease 2019 (COVID-19) patients.

Integrity signals

Registry

Crossref · 10.1111/1753-0407.13091

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Aggarwal, G., Lippi, G., Lavie, C. J., Henry, B. M., & Sanchis‐Gomar, F.
Affiliations
  • Jersey City Medical Center (US)
  • University of Verona (IT)
  • Ochsner Health System (US)
  • Cincinnati Children's Hospital Medical Center (US)
  • Department of Physiology, Faculty of Medicine University of Valencia and INCLIVA Biomedical Research Institute Valencia Spain
Corresponding author
Henry, Brandon Michael
Venue
Journal of Diabetes
Publisher
Wiley
Published
2020-10
Volume
12
Issue
11
Pages
851-855
ISSN
  • 1753-0393 (ISSN-L)
  • 1753-0407
OpenAlex
W3042354321
Cited by
78
References
4
Citations by year
2026: 1 · 2025: 4 · 2024: 7 · 2023: 13 · 2022: 16 · 2021: 28 · 2020: 9
FWCI
2.17
Type
journal article
Language
en
Open access
Locations
  • Journal of Diabetes (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
  • Health Sciences › Medicine › Oncology › COVID-19 and healthcare impacts
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Keywords
diabetes mellitus, COVID-19 pandemic, SARS-CoV-2, disease severity, mortality, comorbidities, pooled analysis
MeSH terms
Betacoronavirus, COVID-19, SARS-CoV-2, Adolescent, Adult, Aged, Aged, 80 and over, Cause of Death, Diabetes Mellitus, Female, Humans, Male, Middle Aged, Pneumonia, Viral, Prognosis, Risk Factors, Severity of Illness Index, Time Factors, Coronavirus Infections, Risk Assessment, Host-Pathogen Interactions, Young Adult, Pandemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review